Sign in
Enrolling by invitationNo phase

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Key facts

Who runs it
Beckman Coulter, Inc.
Where
Augusta, Cincinnati, Cleveland, Columbus, Hackensack, Indianapolis, Irvine, Kansas City, and Raleigh, United StatesSee the 10 sites
Trial code
Status
Enrolling by invitation
People taking part
40,000 people, planned
Started
15 Feb 2021
Expected to end
31 Dec 2026
Type of study
Observational
Record updated
21 June 2024

Who can take part

Age
18 years to 89 years
Sex
Women and men

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • All races, ages and ethnicities
  • All patients admitted to the hospital or presenting to the Emergency Department

Who cannot take part

  • Patients not presenting to a hospital setting (e.g. urgent care, outpatient clinic excluded)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 89 years old?

Where in United States

  • Augusta University Medical SchoolAugusta, United StatesEnrolling by invitation
  • University of CininnatiCincinnati, United StatesEnrolling by invitation
  • MetroHealth SystemsCleveland, United StatesEnrolling by invitation
  • The Ohio State UniversityColumbus, United StatesEnrolling by invitation
  • Hackensack University Medical CenterHackensack, United StatesEnrolling by invitation
  • Indiana University HealthIndianapolis, United StatesEnrolling by invitation
  • University of California, IrvineIrvine, United StatesEnrolling by invitation
  • University Health Truman Medical CenterKansas City, United StatesEnrolling by invitation
  • University of Kansas Medical CenterKansas City, United StatesEnrolling by invitation
  • WakeMed HealthRaleigh, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.

The group in the trial

  • Primary Objective: Severe Sepsis

    The primary endpoint for this study is defined as the presence of sufficient data for SOWS training and algorithm development to proceed with subsequent validation. To provide sufficient data subsets (severe sepsis EHR encounters) for training and validation of the Sepsis Onset Warning System algorithm. There will not be any interventions administered.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Sepsis Onset Warning System [SOWS] Master Enrollment Study Protocol
Fit questions
Built from NCT05304728, who can take part
Record updated
21 June 2024